ENCEPHALITIS PROTOZOAL

ENCEPHALITIS PROTOZOAL was reported 56 times

ENCEPHALITIS PROTOZOAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 6 0.0047
1 Nucleoside Analog Antifungal [EPC] 3 0.0021
2 Sulfonamide Antibacterial [EPC] 3 0.0008
3 Antimalarial [EPC] 7 0.0007
4 Antiprotozoal [EPC] 7 0.0007
5 Antimetabolite Immunosuppressant [EPC] 7 0.0003
6 Lipid-based Polyene Antifungal [EPC] 4 0.0003
7 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0002
8 Penem Antibacterial [EPC] 6 0.0002
9 CD52-directed Cytolytic Antibody [EPC] 3 0.0002
10 Glycopeptide Antibacterial [EPC] 7 0.0001
11 Polyene Antifungal [EPC] 4 0.0001
12 CD30-directed Immunoconjugate [EPC] 1 0.0001
13 Azole Antifungal [EPC] 12 0.0001
14 Nitroimidazole Antimicrobial [EPC] 4 0.0001
15 CD20-directed Cytolytic Antibody [EPC] 14 0.0000
16 Nucleoside Analog Antiviral [EPC] 3 0.0000
17 Corticosteroid [EPC] 42 0.0000
18 Alkylating Drug [EPC] 7 0.0000
19 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
20 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
21 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
22 Fluoroquinolone Antibacterial [EPC] 2 0.0000
23 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
25 Benzodiazepine [EPC] 4 0.0000
26 Opioid Agonist [EPC] 1 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
28 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000